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Chapter 1
Introduction
Let us talk about brains.
Or rather, let us take a step back and talk about minds.
Specifically, let us consider the question once posited by Allen Newell (1):
How can the human mind occur in the physical universe?
It is not trivial to understand what this question means. We know about
brains, of course. And while consciousness may be difficult to pin down in an
exact definition, it is somewhat akin to art, in that we know it when we see it.
Yet for all that, and decades of research, not one among us can create a human
mind. Other than through the, shall we say, primitive method of course, but
that one involves creating quite a bit of unrelated biology to go with it so it
does not count∗.
To study the mind then we resort to studying the components that some-
how produce a mind. After invalidating some early alternative hypothesis (3),
the general consensus appears to be that brains are somehow involved. Of
course, one can divide the brain into smaller components, such as the forebrain,
midbrain and hindbrain. In turn, we can divide these into further components,
such as the cortex and basal ganglia. Which can subsequently be divided even
∗Though possibly not quite as unrelated as all that (2).
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further into nuclei like the striatum, wherein we find neurons and neuroglia, and
these groups we can again divide further ad nauseum.
Essentially, it is components all the way down.
“What then”, the young and indubitably naive neuroscience student wants to
know, “is the component we should study?”.
And the answer is of course a resounding “whatever it is your advisor stud-
ies”.
In this thesis then I shall endeavour to broaden our understanding of how
the human mind can exist through a reductionist approach that limits itself out
of necessity† to the basal ganglia, with particular focus on interneurons in the
dorsal striatum and nucleus accumbens.
Ow alright then, and a bit of mesencephalon.
†And a strong desire to not go insane.
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Chapter 2
A brief history of the Corpus
Striatum
2.1 Striatal function & anatomy
The striatum is classically thought of as an input structure to the basal ganglia,
a group of subcortical nuclei involved in e.g. motor control, habit formation
and reinforcement learning. The anatomical description of this region, striatum
for its striped appearance, belies its functional organization: dense fibre bundles
originating in the cortex travel through and connect throughout the striatum,
as illustrated in figure 2.1.
While the basal ganglia were first observed by the anatomist Andreas Vesalias (4),
it was Thomas Willis who noted the striped appearance of what is now known
as the Corpus Striatum (5). He proposed a role for the striatum in motor control
after observing degeneration of this structure in the brains of patients that had
suffered from paralysis. Remarkably, some of his theories still hold up centuries
later, a testament to the invaluable knowledge one may obtain from a thorough
study of anatomy - though it should be noted that Willis and indeed others (6)
ultimately placed too much importance on this structure.
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Figure 2.1: A parasagittal view of the mouse striatum, with fiber bundles orig-
inating in the cortex (top, left) seen projecting through the striatum to down-
stream nuclei. Silberberg lab, unpublished.
Exploring the full extend of afferent pathways remains an active quest to
this day; simple tracing studies highlight a host of cortical and subcortical areas
projecting towards the corpus striatum, as illustrated in figure 2.2. For some
time, the intimate connection between cortex and striatum meant the latter was
considered a relay station for, and integral part of, the descending pyramidal
tract (7). In part this ubiquitous innervation long hampered an exact determi-
nation of its functional role. As Wilson wrote (8) around the turn of the century:
Under these circumstances the question of its function became an
enigma, and, as a consequence, there was eventually assigned to it
a varied assortment of motor, sensory, vasomotor, psychical and
reflex functions, no one of which, it is safe to say, has ever rested
on unequivocal evidence.
Evidently, for a structure so widely connected to other parts of the brain, the
striatum could easily be demonstrated to be involved in a plethora of functions
without necessarily being solely responsible for any one specifically. This did
not elude scholars of the time, who took care to describe the striatum as orga-
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Figure 2.2: A retrogradely tracing virus illuminates cortical and subcortical
areas projecting towards the injection site in dorsal striatum. Silberberg lab,
unpublished.
nizing movement rather than initiating it (9). Crucial to making this distinction
was the advent of electrical stimulation to limit excitation of brain tissue more
specifically to e.g. the corpus striatum, without innervation of the surround-
ing cortex (10). Thus the most noble of scientific disciplines, electrophysiology,
ultimately finds its origin in scholars like Hitzig and Ferrier (7).
2.2 Dopaminergic innervation of the striatal mi-
crocircuit
It took more time and arguably the discovery of neuromodulators before the
exact role of the corpus striatum could be further investigated. The anatomical
link between the striatum and its downstream targets, including the substantia
nigra, was well established by this time (8):
The striofugal groups preponderate, and link the globus pallidus with
the optic thalamus and the regio subthalamica, including the nucleus
ruber, corpus subthalamicum, and substantia nigra.
5
Likewise the pathophysiology of Parkinson’s Disease, neurodegeneration in
the Substantia Nigra pars Compacta, was remarked upon not much later (11).
However, while dopamine had been synthesized years before (12–14), its ubiq-
uitous presence in the brain was only established in 1957 when Montagu ob-
served 3-hydroxytyramine in brain tissue (15). Initially assumed a relatively
inert intermediate compound to more important catecholamines, some evidence
suggested it occupied a physiological role by itself (16). It soon followed that
dopamine could reverse the lethargic effects produced by reserpine, a vesicu-
lar monoamine transporter. This was demonstrated initially in rabbits (17) and
later in humans (18) as well. Carlsson subsequently used a new fluorescent assay
technique to demonstrate that reserpine depleted dopamine in the brain, an
effect which could be counteracted by L-dopa.
The observation that dopamine was indeed depleted in the brains of patients
with Parkinson’s Disease (19,20) soon confirmed its role in this disease, further
evidenced by the discovery of a dopaminergic nigrostriatal pathway (21). Even-
tually this led to the abandoning of anticholinergic treatments prevalent at the
time (22) in favour of the L-dopa based treatments that are still in use to this
day (23), as they induce fewer and less severe side-effects.
Of course, this raised the issue of acetylcholine: since a reduction of striatal
acetylcholine produced the same effect in Parkinson’s Disease as an increase in
striatal dopamine, it was soon speculated that the two neuromodulators served
antagonistic roles in controlling striatal activity (24). As Donald Calne writes in
1971 (25):
Normally there is a balance. In Parkinsonism dopaminergic func-
tion is reduced, so that the balance is disturbed in the direction of
cholinergic dominance.
This notion would soon receive scrutiny (26) and indeed become more nuanced
over time, yet it was still nominally accepted that dopamine and acetylcholine
played antagonistic roles until almost half a century later (27).
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2.3 Cholinergic innervation of the striatal mi-
crocircuit
Shortly after its discovery, the substantia nigra pars compacta was inferred
to be the source of striatal dopamine, as a decrease in dopamine appeared to
correlate with neural degeneration observed in patients with Parkinson’s Dis-
ease (11,19,28). Around that time the presence of acetylcholine in brain tissue was
demonstrated (29,30) and the then novel theory of neurotransmitter release from
synaptic vesicles gained traction (31).
Electrophysiological recordings in the cerebral cortex of cats by Krnjević
and Phillis demonstrated the existence of neurons sensitive to acetylcholine (32),
thereby confirming its functional role within the central nervous system, and
suggesting a layer-specific localization of acetylcholine-sensitive neurons. In
later work, Krnjević also observed clear staining on striatonigral fibres of acetyl-
cholinesterase, the primary enzyme catalysing the breakdown of acetylcholine,
which may proof relevant later (33). By then, the presence of acetylcholine in the
brain (34) and the relatively high levels of acetylcholinesterase within the corpus
striatum had been well established (35) and indeed linked to its involvement in
Parkinson’s Disease, as Feldberg and Vogt write (36):
The fact that administration of atropine in Parkinsonism can partly
compensate for the loss of these centres is interesting in this respect,
although it is not possible at the moment to offer any explanation,
since the mechanism of the inhibitory action of these centres is any-
thing but understood.
The methods available at this time did not yet allow for the unambiguous
identification of neurons producing acetylcholine, merely the detection of acetyl-
cholinesterase. Together with the low prevalence of cholinergic neurons in the
corpus striatum this meant the origin of striatal acetylcholine would remain
enigmatic for some time yet.
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Putative cholinergic neurons in the corpus striatum had been described as
Giant Neurons using the Golgi method (37), yet their cholinergic nature could not
be confirmed until improved methods of immunocytochemistry became avail-
able. The presence of local cholinergic neurons was demonstrated in the corpus
striatum of the rat when lesioning striatal afferents did not produce a reduction
in acetylcholine levels (38,39). This assumption was only recently invalidated by
the discovery that the pedunculopontine and laterodorsal tegmental brainstem
nuclei also provide cholinergic innervation of the striatum (40).
Bolam et al. first demonstrated that the striatal Giant Interneurons in
rats were cholinergic in nature (41), which ultimately established that neurons
identified electrophysiologically as Tonically Active Neurons (TANs) (42,43) were
indeed predominantly Cholinergic Interneurons (ChINs) (44–46), though notably
interneurons expressing somatostatin are also capable of tonic firing in the ab-
sence of extrinsic excitation (47).
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Chapter 3
Aims
The research underlying this thesis ultimately aims to elucidate three aspects
of the striatal circuit: how dopamine and acetylcholine interact, the role of
GABAergic interneurons in the striatal microcircuit, and how these interactions
can be understood in a systematic way through computational modelling.
Aim 1: Understanding network effects of dopamine
input and cholinergic modulation on striatal func-
tion
While this thesis focuses on striatal interneurons, we should not loose sight
of the projection neurons which make up some 95% of striatal neurons. These
Medium Spiny Neurons (MSNs) can be divided further in D1-receptor expressing
direct-pathway dMSNs and D2-receptor expressing indirect-pathway iMSNs (48).
This differential expression of D1 and D2 receptors, combined with selective
expression of various other markers such as enkephalin (49), substance P (50,51),
and dynorphin (52) results in two electrophysiologically similar, yet functionally
very distinct populations of projection neurons. Therefore any modulation of
the striatal circuit should be understood in light of these uniquely modulated
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groups. In study 2, 3 and 4 of this thesis we sought to further understand how
cholinergic and dopaminergic modulation affects projection neurons, investigate
glutamate and 𝛾-aminobutyric acid (GABA) co-release from dopamine neurons
and how dopamine release affects cholinergic interneuron communication.
Aim 2: Examine the striatal microcircuitry at a
network level
It quickly becomes unfeasible to formulate clear explanations of the striatal net-
work that incorporate recurrent interactions between projection- and interneu-
rons combined with the plethora of retrograde input from striatal output nuclei.
As we shall discuss later, this may be partially remedied by modelling these in-
teractions computationally∗. To retain some semblance of tractability, for now
this thesis shall focus on describing the most dominant interactions resulting
from these pathways, in light of the publications included in this thesis. In
study 2 and study 5 we developed computational models arising from exper-
imental results with the goal of elucidating dopamine modulation (study 2)
and interneuron interactions (study 5). While they do not yet encompass all
the interactions described here, they may serve as a starting point for further
computational studies.
Aim 3: The functional role of striatal GABAergic
interneurons
While this thesis predominantly focuses on dopamine and acetylcholine, the
bulk of inhibition modulating Medium Spiny Neuron (MSN) activity arises from
parvalbumin-expressing fast spiking interneurons (53–55). In turn, Fast Spiking
Interneurons (FSIs) receive VGLUT3-dependent cholinergic innervation (56) gat-
ing their inhibition of MSNs. This highlights the importance of investigating
∗If indeed it has not become too complex even for computational models to explain.
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not only direct activation and inhibition of MSNs by neuromodulators, but also
indirect effects from those neuromodulators on the local circuit gating striatal
outputs. In study 1 we investigate the role of FSI subpopulations in a pathway-
specific manner.
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Chapter 4
Cholinergic and Dopaminer-
gic modulation
4.1 Dopaminergic modulation of striatal func-
tion
The importance of dopaminergic afferents in striatal function can perhaps best
be described through the steady increase of complexity ascribed to these affer-
ents through the years. Rather than simply providing a blanket of dopamin-
ergic innervation, dopaminergic neurons in the substantia nigra pars compacta
and ventral tegmental area are now known to co-release GABA (57) and glu-
tamate (58) in a target-specific manner and exhibit local axo-axonal control
through nicotine receptors (59). Ergo, a single dopaminergic axon may simul-
taneously excite, inhibit and modulate specific afferent targets over multiple
time-scales.
Dopamine can also modulate GABA release onto cholinergic interneurons (60),
affecting recurrent inhibition between cholinergic neurons and their feed-forward
modulation of MSNs. This further complicates their modus of action as illus-
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Figure 4.1: Dopamine and acetylcholine in the striatum form a complex web of
interactions, not limited to those depicted here. Note that most forms of mod-
ulation are cell-state dependent and may reverse direction under certain condi-
tions. iMSN: indirect pathway Medium Spiny Neuron, dMSN: direct pathway
Medium Spiny Neuron
trated in figure 4.1.
Thalamic and cortical innervation of striatal ChINs moreover enables indi-
rect control over dopamine release (61,62) in a spatially precise manner (63). Vice
versa, as thalamostriatal afferents express nicotinic acetylcholine receptors (64),
ChINs form a reciprocal network of modulation between these thalamic affer-
ents and their postsynaptic targets, including other ChINs. Therefore midbrain
dopamine neurons acting on striatal ChINs may indirectly tune thalamostriatal
and corticostriatal inputs onto Medium Spiny Neurons, in addition to their di-
rect modulation of these projection neurons through dopamine D1 and D2 recep-
tors. Further interactions not depicted in figure 4.1 include direct and indirect
modulation of FSIs by ChINs (65), dopamine-mediated inhibition of GABAer-
gic inputs onto striatal ChINs (60) and tuning of synaptic plasticity on longer
timescales (66,67).
Historically, the effect of dopamine on striatal function is that it produces
excitation of direct-pathway MSNs and inhibition of indirect-pathway MSNs.
Indeed this text-book (68) description of the role of dopamine provides a wonder-
ful explanation for the physiological changes observed when striatal dopamine
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levels are altered under pathological conditions. It is unfortunately also an
oversimplification of its real complex web of interactions.
Two roles that have traditionally been ascribed to dopamine are those of
relaying reward (69) or salience (46,70) information, and to gate movement ini-
tiation (71) by its opposing modulation of indirect- and direct-pathway MSNs.
Other roles include tuning sensory processing (72,73) in a pathway-specific man-
ner (74), priming for motor responses (75) and facilitating corticostriatal synaptic
plasticity (67,76,77). Detailed knowledge of the local and global mechanisms for
dopamine release is vital to understanding and predicting the origin of deficien-
cies produced by altered dopaminergic transmission within the striatal micro-
circuit.
4.2 Cholinergic modulation of striatal function
The role of dopamine in striatal function is inseparably entwined with that of
acetylcholine. It is the yin to dopamine’s yang, providing similar but not iden-
tical information (78), in a surprisingly different manner (46), strongly related to
reward and salience (79). The striatum receives some cholinergic innervation
through projections from the pedunculopontine and anterodorsal tegmental nu-
cleus (80), however the bulk of striatal acetylcholine is produced by local cholin-
ergic neurons. An uptick in dopamine often coincides with a pause in these local
cholinergic neurons (81) and it is this temporary shift in balance that ultimately
effects the brief window of synaptic plasticity necessary for learning (66,82,83). A
cessation of cholinergic innervation induces long term depression in corticostri-
atal afferents (84) that synapse onto MSNs. The cholinergic and dopaminergic
system thus cooperate to modulate striatal outputs on longer time-scales (85).
This learning is impaired when only cholinergic neurons are activated (86), em-
phasizing the need for both modulators to work together.
For tonically active neurons, a pause response (81) may carry as much in-
formation as a burst. We should therefore not take their opposite changes in
firing rates to mean that cholinergic neurons and dopaminergic afferents play
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antagonistic roles (27). Rather imagine an orchestra where one section occa-
sionally pauses to let us hear a different group of instruments. In the case of
striatal cholinergic interneurons, their normal range is a widespread innerva-
tion of almost all known neuron types in the striatum, primarily through an
array of muscarinic receptors. They may further control striatal inputs through
acetylcholine receptors expressed on the axons of both midbrain and cortical
projections (87).
Figure 4.2: Cholinergic neurons exert direct and indirect control over a vast
number of striatal neurons. Through a combination of nicotinic and muscarinic
receptors, ChINs can selectively up- or downregulate activity in almost all known
neuron types in the striatum, as well as regulate thalamostriatal and corticos-
triatal efferents.
4.2.1 Synaptic targets of cholinergic neurons
Some of the known cholinergic neuron interactions are depicted in figure 4.2.
Through a combination of nicotinic and muscarinic receptors selectively ex-
pressed on various striatal neurons and afferents, ChINs can regulate dopamine (62,88)
and GABA release from mesencephalic dopamine neurons (89), mediate feed-
forward GABA release from local interneurons (90–94) and control thalamic (64,95)
and cortical (87) input onto MSNs. On longer time-scales, ChINs can also mod-
ulate short (96) and long-term plasticity of these latter inputs to update the stri-
atal circuit in response to novel stimuli (97). There are several recurrent loops
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in the ChIN efferent network, including their modulation of and by somato-
statin expressing interneurons, direct activation of and inhibition by Tyrosine-
Hydroxylase expressing interneurons and excitation of and inhibition by mes-
encephalic dopamine axons as depicted in figure 4.1. The resulting network
displays a complex emergent behaviour that may produce counter-intuitive ef-
fects on striatal output.
4.2.2 Inputs to Cholinergic neurons
ChINs are somewhat more selective in whom they listen to (98): ChINs receive
innervation from cortical (88,99,100), thalamic (64,101) and mesencephalic (102,103)
projection neurons, and locally from interneurons expressing somatostatin, tyrosine-
hydroxylase and to a lesser extend the 5-hydroxytryptamine 3A (5HT3𝐴) recep-
tor (104). Dopaminergic control over ChINs is enacted through widely expressed
D2 receptors (105) which may effectively inhibit cholinergic signalling (106). Glu-
tamatergic innervation from cortex and thalamus is relatively weak (101), though
the tonically active nature of striatal ChINs implies that less excitation may
be required to produce increased firing in vivo. The functional role of local
GABAergic innervation is not fully understood and likely to be cell-type spe-
cific, but may play a role in effecting the synchronized activity observed in
ChINs, particularly with regard to their ability to pause firing during salient
events.
4.2.3 The ChIN pause response
Recordings from TANs in alert non-human primates provided the first insights
into their propensity to respond to conditioned sensory stimuli. Aosaki et. al.
described this behaviour in 1994 (107) as follows:
The responses consisted of a pause in firing that occurred -90 msec
after the click and that was in some cells preceded by a brief activa-
tion and in most cells was followed by a rebound excitation.
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Moreover, it became apparent that TANs can exhibit a high degree of syn-
chronicity in their activity, which increased under Parkinsonian conditions (43).
These observations suggest a reward-related signal induces this pause response
in striatal cholinergic interneurons, which may further spread through lateral
communication. The pause in firing following a reward has since been demon-
strated across species, as illustrated in figure 4.3.
Figure 4.3: Cholinergic neurons exhibit a pause in firing following reward. Left:
this pause is demonstrated here in non-human primates; adapted from Raz et
al (43). Right: a similar pause response following reward can be observed in mice
(Silberberg lab, unpublished data).
Various hypothesis have been proposed and indeed have been demonstrated
to be capable of producing a pause in ChIN firing (108). However, the exact
mechanism underlying this pause response in vivo remains disputed. The co-
incidence with an increase in firing of mesencephalic dopamine neurons (46,109)
suggests a possible coupling, further evidenced by the inhibitory effect through
both GABA𝐴 and Dopamine D2 receptors on striatal ChINs. Contradicting
this hypothesis is the observation that ChINs can still exhibit a pause response
when midbrain dopamine neurons have been selectively lesioned (107), be it less
frequently. An alternative explanation lies in synchronized modulation of their
relatively strong thalamic drive, or perhaps by a temporary decrease of cortical
innervation (110).
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Given the plethora of methods capable of producing a pause in tonic firing,
it is not improbable that the ChIN pause response is an innate feature of these
neurons which may be triggered externally by any sufficiently capable source.
This would in fact fit well with the role of the corpus striatum as an integrator:
if the pause marks a physiologically relevant stimulus, different sources may
need to trigger it in whichever way they can. As Wilson writes (111):
The duration and even the sizes of spontaneous and driven hyper-
polarizations and pauses in spontaneous activity in cholinergic in-
terneurons are largely autonomous properties of the neuron, rather
than reflections of characteristics of the input eliciting the response.
Thus one could argue that a pause in ChIN firing is similar to observing an
action potential in other neurons: something that does not have, or does not
need, one specific trigger. While rather unsatisfactory as far as explanations
go, it would account for the various methods by which the pause can seemingly
be elicited. This also opens the possibility of an additional local mechanism for
broadcasting a pause response between neighbouring ChINs: if various ChINs
may be sensitive to pausing on different inputs, a local mechanism for synchro-
nization could spread the pause to ChINs not receiving that initial trigger.
4.2.4 Recurrent inhibition controlling striatal ChINs
One enigmatic but plausible pathway for this lateral spreading of a pause re-
sponse may be the recurrent inhibition discovered to connect striatal ChINs (112,113).
Cholinergic neurons receive strong GABAergic inputs that may be triggered
experimentally through extracellular stimulation of cholinergic fibres or direct
(optogenetic) activation of cholinergic neurons. This lateral inhibition does not
appear to rely on glutamatergic activation of intermediate neurons but can be
blocked by antagonizing either nicotinic acetylcholine receptors or GABA𝐴 re-
ceptors.
The source of this strong GABAergic inhibition remains poorly understood.
Plausible explanations include the GABA co-release observed to originate in
18
mesencephalic dopamine neurons (89,114), direct inhibition by mesencephalic GABAer-
gic neurons projecting to dorsal Striatum, local fast adapting interneurons that
mediate disynaptic inhibition onto medium spiny neurons (92), GABAergic palli-
dostriatal neurons that selectively target ChINs (98), the Neuropeptide-Y Neu-
rogliaform (NPY-NGF) GABAergic interneurons that receive thalamic input via
striatal ChINs, or Tyrosine Hydroxylase (TH) expressing interneurons that re-
ceive direct thalamic input and innervate ChINs (95). Less plausible mechanisms
include direct axo-axonal activation of local neurons which do not otherwise
connect to striatal ChINs such as the parvalbumin-expressing fast spiking in-
terneurons, or direct innervation from GABAergic corticostriatal afferents (115).
In study 4 of this thesis we eliminate most of these possible mechanisms
and demonstrate reciprocal connectivity between ChINs and local TH expressing
interneurons, which accounts for some (but not all) of this recurrent inhibition.
4.2.5 Other sources of cholinergic innervation
Contrary to the findings of McGeer (38) and Lynch (39), external sources of acetyl-
choline have been discovered to innervate the corpus striatum after all (40).
Cholinergic neurons in the pedunculopontine and anterodorsal tegmental nu-
cleus innervate both the corpus striatum and dopaminergic neurons in the Ven-
tral Tegmental Area (80). Activity of these neurons inhibits striatal MSNs, while
exciting local ChINs. Relatively little is known about these extrinsic sources
of acetylcholine, but evidence suggests cholinergic neurons in the pedunculo-
pontine nucleus are involved in learning habitual behaviour, while cholinergic
neurons in the laterodorsal tegmental nucleus control encoding of goal-directed
behaviour (116). At present, interactions between these regions and other striatal
neurons remain elusive, in part due to difficulties in preserving this pathway for
ex vivo electrophysiology.
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4.3 Modulation of striatal output by local in-
terneurons
The dominant form of output modulation by local interneurons is enacted
through parvalbumin-expressing fast spiking interneurons. These exert pow-
erful control over MSNs in their vicinity (53). Long considered a homogeneous
population, in study 1 of this thesis we demonstrate that subpopulations of
fast spiking interneurons inhibit MSNs in a pathway specific manner (117). Fur-
thermore, following a loss of dopamine this subpopulation of FSIs update their
connectivity to preferentially inhibit indirect-pathway MSNs (118).
Fast Spiking interneurons are laterally connected through both GABAergic
synapses and gap junctions (119,120). They selectively target MSNs and other
Fast Spiking interneurons, weakly innervate Low Threshold Spiking interneu-
rons, and generally avoid synapsing onto Cholinergic interneurons (55).
Fast spiking interneurons are modulated on longer timescales by dopamine
and acetylcholine through expression of metabotropic G-protein coupled recep-
tors. They are however primarily driven on shorter timescales by powerful exci-
tation from corticostriatal and thalamostriatal afferents. Fast Spiking interneu-
rons receive stronger and faster cortical input than neighboring MSNs (101),
which suggests a functional role as gatekeepers of striatal input.
4.3.1 Other GABAergic interneurons
The functional role of Fast Spiking and Cholinergic interneurons in the stria-
tum has received extensive attention over the years. Less is known about other
GABAergic interneurons that appear to play a predominantly neuromodula-
tory role. These include those neurons classified electrophysiologically as Low
Threshold Spiking neurons (47,121) that mostly overlap with neurons expressing
Somatostatin (SOM) (122), Nitric Oxide Synthases (NOS) and Neuropeptide-Y
(NPY) (123), the latter overlapping with a population of NPY-NGF neurons (124).
Other populations include Fast Adapting and Spontaneously Active Bursty
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interneurons expressing the serotonin 5HT3𝐴 receptor (125) which may prefer-
entially innervate other interneurons (126), and populations expressing TH, the
calcium-binding protein Calretinin (CR) (127) and Vasoactive Intestinal Polypep-
tide (VIP) (128,129). Some of these interneurons are known to interact with stri-
atal ChINs and to some extend provide poly-synaptic inhibition onto MSNs
following innervation by cortex or thalamus. Less is yet known about the enig-
matic VIP- and calretinin-expressing interneurons, as these populations have
traditionally been difficult to target. In primates but not in mice, CR-expressing
neurons may overlap to some extend with cholinergic neurons (130). As with Fast
Spiking interneurons, subpopulations of CR-expressing neurons can be identified
based on their expression of secretagogin (131).
Figure 4.4: Striatal interneurons and their local connectivity. Most interneurons
inhibit MSNs through fast GABA𝐴 receptors, though slower inhibition has also
been demonstrated. Neuromodulation is not illustrated.
Some of these interneuron populations and their known interactions are de-
picted in figure 4.4. Note that this does not include neuromodulatory effects
arising from e.g. NOS, NPY or Somatostatin which modulate striatal activity
on longer timescales. Not all interactions have been systematically mapped and
for some populations depicted here, connectivity may be subtype-dependent.
This has for example been demonstrated for various subtypes of TH-expressing
interneurons. For other populations including VIP- and CR-expressing interneu-
rons (132), connectivity is largely unknown.
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Chapter 5
Methodology & techniques
The modern neuroscientist has a plethora of techniques at their disposal to
dissect neuronal circuits and understand the functional role of each component.
Here I briefly discuss the various techniques used throughout this thesis, as well
as alternatives and novel approaches that are becoming more viable with further
development.
5.1 Controlling neural activity
5.1.1 Electrical control
Neurons can be excited electrically either individually, through whole-cell patch
clamp electrophysiologically, or regionally through a stimulus electrode. Excit-
ing neurons induces action potentials which travel downstream to enact trans-
mitter release and produce post-synaptic responses in targeted populations. The
so elicited postsynaptic responses can be measured to determine functional con-
nectivity between neuronal populations. The advantage of electrical stimulation
is its exact control over timing, and in the case of whole-cell patch clamping,
precise control over the effective stimulus amplitude on a single neuron level
which provides greater certainty that an evoked excitation directly produced a
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measured postsynaptic effect.
The disadvantage of using a stimulus electrode is its lack of target speci-
ficity, and therefore general inability to distinguish input from locally intermin-
gled populations of neurons. However, when the intended target population
expresses a unique neurotransmitter, it is possible to selectively antagonize re-
ceptors for other neurotransmitters so that their contribution to a recorded post-
synaptic response can be eliminated. For example, Sullivan et. al. (112) recorded
postsynaptic responses to electrical stimulation in the Striatum. They observed
that these responses persisted in the presence of the AMPA receptor antagonist
DNQX, thereby excluding the involvement of glutamatergic afferents. How-
ever, these responses were eliminated following application of nicotinic receptor
antagonists, thus demonstrating that these responses involve acetylcholine and
must therefore be due in part to activation of cholinergic fibres.
However, in situations where multiple presynaptic populations use the same
neurotransmitter, it is often not possible to identify the exact origin of a post-
synaptic response through extracellular stimulation. Whole-cell patch clamping
does not suffer from this limitation when the presynaptic neuron can be identi-
fied through electrophysiological or fluorescent markers; however, when connec-
tions are rare or very weak as is the case for inputs to distal dendrites, it may
not be feasible to ascertain connectivity between various neuron populations.
When the concerted activation of a selective group of presynaptic neurons
is required, optogenetics offers strong advantages.
5.1.2 Optical control
Modern optogenetics (133,134) is the refinement and combination of various tech-
niques into one ready-to-use tool. It incorporates light-gated ion channels with
an effective viral delivery mechanism (135), which may then use the Cre-Lox
system (136) to achieve target-specificity. More specialized variants can achieve
greater temporal control (137) by reducing the post-light activation time, or can
limit expression to somata to reduce unwanted axonal activation. (138).
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Over the years, the optogenetic toolbox has included opsins that function at
different wavelengths (139), opsins that can be switched to a specific state (140),
and opsins that have an inhibitory effect (141). When these opsins are combined
with a structured light source, it becomes feasible to probe hundreds of potential
connections at an individual cell level or selectively inhibit specific neuronal
populations both in slice as well as in vivo.
The main drawback to optogenetic activation or inhibition compared to
whole-cell patch clamp electrophysiology is its lack of feedback. By itself, in-
hibiting a population through light does not guarantee that none of the inhib-
ited cells fire action potentials and vice versa, optogenetic activation does not
guarantee that every targeted cell fires an action potential. This is especially
problematic in two scenarios:
1. When inhibiting part of a poly-synaptic circuit. If a response is not abol-
ished during light-gated inhibition, it is possible the inhibited population
could still fire action potentials or release neurotransmitter. This is es-
pecially problematic for axonal expression of light-gated chloride chan-
nels (142).
2. When using structured illumination to probe single neuron connections.
Since opsin expression in dendrites and axons can contribute to eliciting a
response, limiting the light pattern to only somata is less capable of pro-
ducing suprathreshold responses. Conversely, broadening the activation
spot risks triggering axonal activation of unrelated neurons, resulting in
false positives.
Both of these issues can be resolved to some extend by combining optical
control with optical read-out of neuronal activity (143). This does require com-
patible opsins with no overlapping emission and excitation wavelengths, and
consequently more complex microscopy systems limiting its adoption (144).
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5.1.3 Ligand-gated control
Since most neurons express ligand-gated ion channels, they can be controlled
by precise application of selected neurotransmitters. In its crudest form, ex vivo
preparations may be perfused by low doses of neurotransmitter, unselectively si-
lencing or exciting all neurons in the preparation that express the corresponding
receptor.
Target specificity can be achieved by selective expression of DREADDs: De-
signer Receptors Exclusively Activated by Designer Drugs (145). By using an oth-
erwise inert compound to activate G-protein coupled receptors only expressed
in specific cell-types, a neuronal population can be controlled both in slice and
in vivo without the need for optical or chemical interfaces implanted into the
brain. This makes chemogenetics a very suitable tool for behavioural experi-
ments with freely moving animals. Care should be taken in selecting the ligand:
it must be able to cross the blood-brain-barrier, and importantly, not produce
behavioural effects by itself. This latter restraint came under scrutiny when it
was revealed that the most commonly used ligand at the time, Clozapine-N-
Oxide, metabolizes into Clozapine which is not inert (146).
Greater spatial and temporal precision may be achieved by applying the lig-
and, be it neurotransmitter or receptor agonist, locally through a micropipette.
The ligand can then be ejected by applying pressure, or through current pulses
in case of a charged ligand. While this does not limit ligand spread to exactly
a single neuron, its spread can be finely controlled and the onset time can be
determined to within a fraction of a second.
The most exact control over ligand-gated modulation may be achieved through
2-photon uncaging of a caged transmitter. In essence, the ligand is bound to
a photosensitive component. Upon photostimulation, this releases the ligand.
With the advance of 2-photon activation (147), the location of ligand uncaging
can be limited to individual boutons on an axon (148) which makes this an ex-
ceptional tool for mapping receptor distributions. By now, a wide range of
compounds can be used in uncaging experiments (149).
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Figure 5.1: Each technique for controlling neural activity comes with advan-
tages and disadvantages. These further depend on specific implementations of
each technique, the relative positioning here should therefore only be taken as
coarsely indicative.
An overview comparing the techniques described above is depicted in figure
5.1. Relative positions of each technique depend on specific implementations
and other factors such as the availability of specific ligands, transgenic lines and
structural layout of the targeted population. Other considerations include the
choice of read-out to monitor each form of manipulation and cost to implement,
which may range from several hundred dollars for extracellular stimulation to
hundreds of thousands of dollars for super-resolution 2-photon uncaging sys-
tems.
5.2 Reading out neural activity
Manipulating neural activity serves no purpose without some method of reading
out the resulting effect. In its most simple form, an animal may change its
behaviour in response to altered neural function. For example, administering
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) terminates dopaminergic
neurons in the Substantia Nigra. The result of this manipulation is a clear
measurable change in behaviour (150). However, if we wish to understand this
further, one may probe various neuronal populations to understand how they
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are affected by the manipulation and how their altered function may lead to the
observed behaviour (151).
Doing so also has the not unwelcome side-effect that a rogue cleaner feeding
your pigeons∗ does not mess up your experiment (152). Let us consider techniques
for measuring neuronal activity.
5.2.1 Electrical measurements
When neurons fire action potentials, this changes the potential across their outer
membrane in a measurable way. Hodgkin and Huxley famously demonstrated
this ion-mediated flow of charge across a membrane in their work on the gi-
ant squid axon (153), though electrical activity in the brain had been measured
long before (154). Roughly in order of increased spatial resolution, the follow-
ing techniques are employed to estimate neural activity by measuring electrical
signals:
• Electro-encephalography (EEG) & Magneto-Encephalography (MEG)mea-
sure the electric field and magnetic field respectively that is produced by
thousands of neurons acting in synchrony. Since these signals are typically
detected through the skull, spatial resolution is poor, but they are among
the few non-invasive techniques on this list.
• Local Field Potentials (LFP) measure the electric field of a brain region
in a more precise manner by placing an electrode directly into the area
of interest. This produces stronger signals and better spatial precision
compared to EEG, at the expense of being an invasive technique.
• Silicon probes and single-unit recordings operate by inserting small con-
ducting spots to measure electrical activity of one to a few neurons si-
multaneously directly adjacent to the recording site. Silicon probes can
∗This story was told to me during my undergraduate years in the Netherlands. Apparently
a cleaner took pity on the poor underfed birds, and started feeding them when he came to work
in the morning. For months, the pigeons ignored their food reward, much to the frustration
of their experimenters. This may or may not be an urban legend; as a graduate student, I
like to believe this really happened.
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record from hundreds of spots simultaneously, and since the relative spa-
tial position of each spot on the probe is known, this enables measuring
activity as a function of location between many neurons.
• Cell-attached(155) & perforated-patch electrophysiology measures electrical
activity from the outside of a cell membrane. Since the cell-membrane is
not ruptured, internal processes are not affected. In case of perforated-
patch, pores are formed in the membrane to allow more accurate measure-
ments of the internal electrical signals.
• Whole-cell patch-clamp electrophysiology ruptures the cell-membrane to
form a direct path between the inside of a neuron and a recording elec-
trode. This produces electrophysiological data at high temporal, electrical
and spatial resolution. Unlike cell-attached and perforated-patch record-
ings, this technique affects the intracellular composition of the targeted
cell, which has both advantages and disadvantages.
• Nano-pipettes for subcellular recording(156) decrease the size of the tip of
the patch pipette to achieve subcellular resolution, enabling recording of
electrical activity in individual processes of a neuron.
Most of these techniques are limited in either the number of neurons they
can record from, or the spatial resolution of the data they record. Only silicon
probes can record activity at the individual neuron level for hundreds of neurons
simultaneously. While such probes offer good temporal resolution and accept-
able spatial resolution, they typically cannot measure sub-threshold activity and
are limited in their ability to target specific populations.
5.2.2 Optical measurements
If neuronal activity could be transmitted through light, it would remove many
of the barriers limiting electrophysiological methods of measurement. One can
observe specific neuronal populations in a large area with great spatial resolu-
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tion and, without the need to stick wires into a cell, neurons remain largely†
unperturbed. A variety of techniques have been developed to achieve this:
• Voltage imaging employs fluorescent proteins that change their luminosity
in the presence of a charge or electric field (158,159). When they are bound
to a cell membrane, they can be calibrated to report the membrane po-
tential. Challenges remain to produce voltage sensors that are sensitive
over the entire range of common membrane potentials.
• Calcium imaging works in much the same manner, but the change in lumi-
nosity is brought about by binding to Calcium within the cell. Since these
sensors can be freely expressed within the cytoplasm, calcium imaging typ-
ically produces brighter signals than voltage imaging. Since the change in
luminosity is brought about by binding and releasing of Calcium, signals
only loosely correlate to membrane potential and are typically incapable
of reporting sub-threshold events.
Initial voltage and calcium indicators were applied to tissue as dyes (160),
either intra- or extracellularly. More recently genetically-encoded sensors have
been developed, which may be transduced in a celltype-specific manner. A
plethora of genetic calcium indicators is now available, most famously in the
family of GCaMP (161,162) sensors. In contrast, genetic voltage indicators (163)
are not as commonly used, likely because they typically necessitate more spe-
cialized equipment to obtain adequate signal-to-noise ratios.
5.2.3 Neurotransmitter measurements
To determine neuron activity, we can also observe the functional endpoint of
an action potential: release of neurotransmitter. Multiple methods exist to
do so. Microdialysis and subsequent analysis of cerebrospinal fluid is typically
considered to be accurate but slow, tracking transmitter and neuromodulator
levels over minutes or hours (164). Fast-Scan Cyclic Voltammetry (FSCV) and its
†But as it turns out, not completely (157)
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improved variant, Fast-Scan Controlled-Adsorption Voltammetry (FSCAV) (165)
use the oxidation and reduction of certain transmitters like dopamine to measure
transmitter levels on sub-second scales by inserting a carbon fibre electrode
into the area of interest. While FSCV can only report rapid changes in e.g.
dopamine concentration, this limitation is overcome in FSCAV to accurately
measure absolute levels of the transmitter in question.
In recent years, optical sensors have been developed that undergo a fluo-
rescence change in the presence of a specific transmitter. Examples include the
GRAB𝐷𝐴 (166) and dLight (167) families of sensors for measuring dopamine, with
specific variants tuned to various ranges of transmitter concentrations. These
optical sensors offer much greater spatial resolution when compared to micro-
dialysis and voltammetry and can be used to track dopamine levels over long
time-spans in freely moving animals.
Figure 5.2: Each technique for measuring neural activity comes with advantages
and disadvantages. These depend on specific implementations of each technique
and relative positions are therefore subject to minor deviations.
Figure 5.2 provides a rough overview of how these techniques relate to each
other in terms of spatial and temporal resolution, as well as the signal-to-noise
ratio and how many neurons can typically be observed by each technique. Other
important aspects not illustrated here include the ability to detect sub-threshold
events, applicability in vivo, and ease of implementation, which spans a vast
range between techniques.
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Care should be taken to select compatible techniques for recording and ma-
nipulating neural activity. For example, if blue light is used to image calcium
activity, one typically cannot use blue light to activate opsins in that same area.
Likewise, the strong currents involved in FSCV may interfere with sensitive
patch-clamp and silicon probe recordings. Occasionally, interference may sim-
ply be mechanistic: a large objective for measuring in vivo voltage signals can
obstruct access to the brain for silicon probes and their affixed amplification
circuits.
5.3 Computational Modelling
Computational models are invaluable tools for deciphering complex networks of
interactions. When designing a computational model, the foremost decision is
at what level one should model. When astronomers model the movement of a
planet around the sun, they do not model every grain of sand on the planet, but
rather treat the entire planet as one single entity. So too must we decide which
effects we model in a quantal manner, and which we take as singular entities.
It is tempting to model every ion flowing through a neuronal membrane,
encompass every interaction it may make, and so ultimately derive at the truth.
Unfortunately, this becomes computationally intractable even for a single neu-
ron, nor do we understand all possible chemical interactions well enough to
model these correctly. Instead, a select number of relevant interactions may be
approximated using differential equations that follow mass-action kinetics.
The next level up would be to model currents arising from ionic flow through
various channels (168), express these channels where appropriate along the cell
membrane and compartmentalize parts of the neuron that are more or less iso-
tonic and electrotonic (169). It has recently become feasible to create such models
for larger networks (170). In study 2 of this thesis, we use the NEURON (171)
simulation environment to create a model of a medium spiny neuron, replete
with a range of receptors and channels that may affect its behavior.
One step up from compartmental neuron models are neuronal point-models (172),
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wherein much like our astronomy example above, each neuron is treated as a
singular entity. These can be combined with multi-compartmental models to
provide realistic innervation of a detailed circuit of multi-compartmental models,
as we demonstrate in study 5.
Proceeding to higher levels of cognition we find simulation environments like
ACT-R (173) capable of modelling entire cognitive processes, without a direct
association to neurons. These models go beyond the scope of this thesis, but
may ultimately provide a key link between understanding cognition and neural
activity.
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Chapter 6
Results & Discussion
In sections 3 and 4 I laid out the aims and background for our studies into
striatal function. I shall now endeavour to summarize and discuss the results
from each study included in this thesis in light of these aims.
6.1 The functional role of striatal GABAergic
interneurons
In study 1 we sought to understand the heterogeneity and connectivity of stri-
atal fast spiking interneurons, as described in section 3. Parvalbumin-expressing
Fast Spiking Interneurons are generally considered to comprise a homogeneous
population. We demonstrated that in rats and primates, striatal FSIs can be
divided into distinct subpopulations by their expression of the calcium-binding
protein Secretagogin (Scgn) (174).
In rats, PV+/Scgn+ FSIs differed in their electrophysiological properties
and relation to cortical activity compared to PV+/Scgn- FSIs. Furthermore,
While PV+/Scgn- neurons were uniformly distributed throughout the striatum,
PV+/Scgn+ neurons exhibited an uneven spatial distribution with increased
density in the caudal parts of the rat striatum. Along the mediolateral axis,
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PV+/Scgn+ neurons were more abundant laterally in rostral striatum and me-
dially in the caudal striatum.
Secretagogin expression also determined entrainment to cortical oscillations.
PV+/Scgn+ neurons exhibited an increase in firing during cortical activation
and preferentially phase-locked to gamma oscillations, compared to PV+/Scgn-
neurons which were more strongly locked to spindle oscillations.
Figure 6.1: Highlighting the preferential innervation of direct- and indirect
pathway MSNs (dMSN, iMSN respectively) by subpopulations of fast spiking
interneurons. FSIs expressing secretagogin preferentially innervate direct path-
way MSNs, while secretagogin-negative FSIs favour indirect pathway MSNs
The FSI subpopulations also differed in their efferent connectivity: while
both strongly innervate medium spiny neurons, PV+/Scgn- neurons more read-
ily formed axo-somatic appositions rather than axo-dendritic synapses compared
to PV+/Scgn+ neurons. Further analysis showed that PV+/Scgn+ neurons
form more appositions onto direct pathway MSNs, while PV+/Scgn- neurons
were biased towards indirect pathway MSNs.
An updated version of figure 4.4 is depicted in figure 6.1, to highlight the
preference in projection neuron innervation. As FSIs are thought to precede
MSN firing, this bias may be reflected in their activity relative to when MSNs
become active. This indeed turned out to be the case for PV+/Scgn- neurons
which fired prior to iMSNs but not dMSNs. In contrast, secretagogin expressing
neurons did not fire earlier than iMSNs or dMSNs, providing further evidence
that this population serves a unique role in striatal function.
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It remains yet to be determined whether such subpopulations exist for other
GABAergic neurons in the striatum; indeed, for many defined interneuron pop-
ulations little is yet known about their preferential innervation of direct versus
indirect pathway MSNs, a curious gap in our knowledge of striatal function.
6.2 Network effects of dopamine and acetylcholine
on striatal function
The aim of studies 2, 3 and 4 was to gain better understanding of dopaminer-
gic modulation of the striatal network in general and how this relates to cholin-
ergic neurons in particular. The focus of study 2 was dopaminergic modulation
over short and long time-scales; in study 3 we investigated the role of glutamate
co-release in the nucleus accumbens, and in study 4 we described a novel inter-
action of dopamine on cholinergic neuron communication, and GABA co-release
by dopamine neurons onto striatal neurons.
6.2.1 Dopaminergic modulation over multiple temporal
and structural scales
As discussed in section 4.1, dopamine affects striatal function both directly
by exciting and inhibiting projection neurons, as well as indirectly by altering
cellular properties and affecting synaptic efficacies on longer timescales. To
this end, an appropriate tonic level of dopamine must be maintained on top of
phasic release to regulate fast-timescale motor functions and enable learning of
reward-outcome associations. How these compounding signals are integrated is
fundamental to understanding dopamine modulation of striatal function.
We used a biophysically detailed computational model of a direct-pathway
MSN to determine whether known intracellular mechanisms can give rise to the
fast dynamics observed ex vivo. Current flow through multiple compartments is
modelled, taking into account various ion channels modelled where appropriate
along the membrane of each compartment. The effects of dopamine on ion
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channel conductances were modelled, along with intracellular substrates such
as PKA and cAMP to compute downstream effects.
Through randomized simulations, we determined that primarily potassium
and sodium channels contributed to the modulation of excitability following
dopamine exposure. Specifically, down-regulation of sodium channels decreases
excitability, which can be compensated for by down-regulation of Kv4.2 and K𝑖𝑟
potassium channels.
While PKA stimulation ultimately induced spiking, the mean latency in our
simulations was approximately 1 second, too slow to account for the observed
effects from dopamine in vivo. Other substrates were tested as well: cAMP
produced shorter delays at 890 ms, whereas a G-𝛽𝛾 complex could induce spiking
at 650 ms and hypothetical channel-D1𝑅 complexes triggered spikes after 270
ms. As most of these mechanisms are too slow to explain low-latency spiking,
it is possible that modulation of channels is by itself insufficient to account for
fast dopaminergic activation.
This study highlights the importance of Kv4.2 channels in modulating MSN
excitability following dopaminergic transients; it also illustrates that it remains
poorly understood how signalling cascades ultimately produce the behaviour
observed in vivo. Careful examination of potassium channel complexes within
striatal cells may produce further insights in the future.
6.2.2 Dopamine & glutamate co-release in the Nucleus
Accumbens
Section 4.1 briefly discusses dopaminergic modulation of synaptic plasticity.
Where study 2 focused on downstream effects from dopamine receptor acti-
vation, a further contributing factor to altered synaptic efficacy may be glu-
tamate co-release from dopamine axons originating in the Ventral Tegmental
Area (175,176). In study 3 we examined this mechanism in more detail, particu-
larly with regards to Vesicular Glutamate Transporter 2 (VGluT2) dependence
and changes in AMPA/NMDA ratios.
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The co-release of glutamate from these putative dopaminergic neurons was
shown to depend on VGluT2 (177) in culture and later in rodents, non-human
primates and humans (178). The number of dopamine cells co-expressing VGluT2
is thought to decrease with age, suggesting a decreased relevance in adults.
Testing the effect of embryonic VGluT2 knock-out in adults risks confounding
compensatory effects during development. In this study we therefore developed
a tamoxifen-inducible conditional knock-out transgenic mouse to ablate VGluT2
gene expression only in mature dopamine neurons.
We found reduced postsynaptic glutamate currents in knock-out mice, con-
firming the VGluT2 dependence of glutamate co-release from VTA dopamine
neurons. Unlike embryonic VGluT2 knock-outs, our tamoxifen-induced knock-
out mice did not exhibit decreased amphetamine-induced locomotor sensitiza-
tion. This difference in response to psychostimulant administration highlights
the importance of studying these manipulations isolated from compensatory
mechanisms during development.
A cocaine-induced locomotor sensitization paradigm can be used to shift the
AMPA to NMDA receptor expression ratio in D1 MSNs. Embryonic VGluT2
knock-out mice exhibit greater sensitization to cocaine than controls, an effect
not observed for the tamoxifen-induced knock-out mice. We found no significant
difference in AMPA/NMDA ratio for treated and control embryonic knock-out
mice. In contrast, D1 MSNs in tamoxifen-induced knock-out mice exhibited a
greater AMPA/NMDA ratio under control conditions, which occluded potential
increases following the cocaine-sensitization protocol.
Our results suggest that embryonic knock-out of VGluT2 could promote
addictive-like behaviour. Disruption of glutamate co-release in adults could
shift baseline AMPA/NMDA receptor expression, changing synaptic plasticity
in striatal MSNs. This shift was not seen in animals with embryonic knock-out,
possibly due to compensatory effects during development. This highlights the
role of glutamate co-release from VTA dopamine neurons even in adulthood,
and the need for further studies to investigate the intracellular mechanisms
responsible for these altered synaptic states.
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6.2.3 Dopaminergic modulation of Cholinergic communi-
cation
As alluded to in section 4.2.4, cholinergic neurons in the corpus striatum exhibit
powerful lateral inhibition. In study 4 we sought to understand this lateral
inhibition and investigate the role of dopamine on cholinergic neuron function.
Maintaining the right balance in cholinergic and dopaminergic tone is crucial
for proper striatal function. One key feature of this balance is the sudden shift
that occurs during outcome-reward associations, such as when an animal is
presented with an unexpected reward or an expected reward is omitted. While
dopamine is known to act on cholinergic neurons through D2 receptors, as we
discussed in study 1 many of these interactions are too slow to account for the
observed fast cessation of firing that occurs in vivo. However, the polysynaptic
inhibition between ChINs provides a capable mechanism to alter ChIN firing
and synchrony on short time-scales throughout the striatum.
Most research into feed-forward inhibition induced by cholinergic neurons
uses optogenetics to stimulate multiple ChINs simultaneously and subsequently
record from MSNs. We opted to record up to four ChINs simultaneously ex vivo
and induce lateral inhibition by stimulating only one presynaptic ChIN at the
time. We find high rates of connectivity between individual ChINs up to several
hundred microns apart. This feed-forward inhibition exhibits one-to-many and
many-to-one connectivity, with a single presynaptic ChIN capable of inducing
strong inhibitory postsynaptic currents in multiple neighbouring ChINs. This
inhibition is strong enough to pause tonic firing for several hundred milliseconds.
As this inhibition exhibits long latencies and a dependence on both GABA
and acetylcholine (but not glutamate) receptors, it is likely mediated by a local
GABAergic interneuron. We systematically mapped inputs from various striatal
interneuron populations onto ChINs, and used chemogenetics to subsequently
silence these populations to ascertain their role in mediating the aforementioned
lateral inhibition.
Cholinergic neurons receive strong GABAergic inhibition from local interneu-
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rons expressing somatostatin, Tyrosine-Hydroxylase (THINs) and Neuropeptide-
Y. Interneurons expressing the 5HT3𝐴 receptor only rarely provide weak inner-
vation of striatal ChINs. Vice versa, THINs are strongly innervated through
nicotinic acetylcholine receptors and can be driven to fire bursts of action po-
tentials when exposed to nicotine. In some cases, we found reciprocal innerva-
tion between individual THINs and ChINs. Silencing this population abolished
some, but not all, poly-synaptic inhibition between striatal ChINs.
Since midbrain afferents also release GABA onto striatal neurons (114) and
midbrain dopamine neurons express nicotinic acetylcholine receptors on their
axons (88), we examined the possibility of lateral inhibition mediated by axo-
axonal activation. We discovered robust mono-synaptic GABAergic innervation
of striatal ChINs from both dopaminergic and GABAergic midbrain neurons.
Chemogenetic silencing of these afferents did not affect poly-synaptic inhibi-
tion between ChINs, eliminating these afferents as possible mediators of ChIN
communication.
Figure 6.2: Cholinergic neurons communicate laterally through a polysynaptic
pathway that is reliant on nicotinic acetylcholine receptors and GABA𝐴 re-
ceptors. This pathway is partially mediated by TH interneurons. Dopamine
effectively suppresses this communication.
In contrast, we noticed strong attenuation of ChIN communication imme-
diately following activation of dopamine afferents. We observed that dopamine
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acting on D2 receptors blocks polysynaptic inhibition between striatal ChINs.
This suggests an novel form of reciprocal control between the striatal dopamin-
ergic and cholinergic systems as illustrated in figure 6.2. As a correct balance
between these neuromodulators has proven to be essential for proper striatal
function, this additional form of control has important implications for under-
standing how striatal function is affected in pathological conditions. A decrease
in dopaminergic tone may for example increase lateral communication, leading
to excess synchrony between ChINs. This has indeed been observed in Parkin-
sonian non-human primates (43). It remains yet to be understood whether these
effects relate to excessive neural oscillations observed in the human Parkinsonian
state.
6.3 A framework for striatal function
Our investigations into the microcircuits of the corpus striatum ex vivo allowed
us to build a network model of these interactions in silico. While circuit models
of this nature existed, they often focused on a subset of interactions and neuronal
subtypes. In study 5 we endeavoured to build a nearly full-scale model to
mimic the bulk of connectivity observed in the corpus striatum. Furthermore,
as the corpus striatum does not operate in isolation, this model incorporates
simulated input from cortex, thalamus and the midbrain. It is designed for
expandability, so that the model can be updated with future advancements in
our understanding of the striatal microcircuit.
The basis for our model consists of reconstructed neuronal morphologies.
These are based on neurons labelled during patch-clamp electrophysiological
recordings and subsequently traced using NeuroLucida (179). This ensures that
our models are based on realistic neuronal morphologies, which can be com-
bined with the appropriate electrophysiological characteristics of each neuron.
These neuron models are then populated with appropriate ion channels and
conductances based on RNA-sequencing data for each cell-type and tuned using
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BluePyOpt∗ to match the ex vivo electrophysiology data as closely as possible.
Based on cell-counts and neuron density estimates, we populated a striatum
volume with the following neuronal subtypes: 47.5% dMSN, 47.5% iMSN, 1.3%
FSI, 1.1% ChIN and 0.8% LTS. Neurons were placed homogeneously throughout
the volume, with a small exclusion zone around each soma to prevent overlap.
Putative synapses are placed wherever axons and dendrites are within close
proximity to each other, with subsequent pruning applied to match experi-
mentally observed connection probabilities. Connections are based on relevant
neurotransmitters and receptor subtypes, so that e.g. MSNs express primar-
ily muscarinic acetylcholine receptors, LTS neurons form GABAergic synapses
on distal dendrites of MSNs and ChINs, and ChINs form both nicotinic and
muscarinic synapses with other neurons. Short term plasticity was fitted to
experimental data using a Tsodyks-Markram model, matching observed facil-
itation and depression. An overview of the connectivity rates between neural
subtypes is provided in figure 6.3.
Figure 6.3: Schematic overview of the connectivity within our model of dorsal
striatum. Connection probabilities are distance-dependent and indicated here
numerically between neural subtypes. Rates in red indicate connectivity at
50𝜇m, in blue at a distance of 100𝜇m. Adapted from Hjorth et al, 2020 (180)
We next ran simulations with 10,000 neurons, receiving cortical and thalamic
input, as they were being modulated by a dopaminergic signal. As expected,
∗See https://github.com/BlueBrain/BluePyOpt
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the dopamine signal altered activity in MSNs and interneurons in a cell-type
specific manner; following the signal, ChINs responded with increased rebound
activity thus matching some of the interactions between the dopaminergic and
cholinergic systems observed in vivo.
While further work can be done to improve the accuracy of our model, in
its current state it provides a powerful tool to study changes in striatal input
and how those affect projection neuron activity. By making this model openly
available, it may be used as basis for computational studies and experimental
verification of altered connectivity states observed under pathological condi-
tions. Despite the current lack of some interactions, most notably from TH,
NGF and 5HT3𝐴 expressing interneurons, it faithfully mimics observed striatal
dynamics. Long-term plasticity, arising for example from internal signalling cas-
cades as modelled in study 2, may be introduced, and e.g. cortical input can
alternatively be provided through detailed cortical models.
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Chapter 7
Conclusions & Perspectives
In this thesis and the accompanying manuscripts, I discussed our current un-
derstanding of the striatal microcircuit and endeavoured to elucidate the enig-
matic interplay between striatal interneurons, projection neurons and the vari-
ous sources of input that control them. The studies discussed here build on a
century of knowledge, filling in some gaps of how the corpus striatum is con-
nected and illustrating where our understanding is still limited. I have focused
here primarily on midbrain modulation of striatal function, yet the corpus stria-
tum receives input from many sources and a holistic approach is fundamental to
connecting these disparate truths. We have made some headway towards this
goal by creating a large-scale network model of the striatum and its inputs, but
complex though this model is, it is far from complete.
It is my hope that this thesis at least illustrates the complexity of striatum
and midbrain interaction. The combination of neurotransmitter co-release, in-
direct effects on synaptic plasticity, slower neuromodulatory effects on neuronal
function and multiple recurrent network effects all complicate what was once
thought to be a simple up-/downregulation of medium spiny neurons. Much
work needs to be done to further confirm how and on what timescales dopamine
and glutamate change the striatal circuit, how these inputs target the lesser
studied striatal interneurons, what role these other interneurons play in con-
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necting and modulating cholinergic neurons and spiny projection neurons, and
how this ties in to the broader network of innervation and modulation present
in the corpus striatum.
For the most part, this thesis ignores the striatal subdivision into matrix
and striosome compartments; this too deserves further investigation if we wish
to complete our understanding, especially in light of the reported uneven lo-
calization of cholinergic neurons in these areas (181). Likewise, not all areas of
the corpus striatum are equally innervated by midbrain, cortical and thalamic
afferents and this too may have important ramifications for our understanding
of the striatal microcircuit as it is presented here. While we are able to ex-
plain some phenomena through our limited depiction of a homogeneous striatal
microcircuit, it is unknown whether these predictions hold up when applied
to a heterogeneous distribution of neurons and projections. This was briefly
glimpsed upon in our studies into subtypes of parvalbumin-expressing interneu-
rons, where we demonstrate that a spatially heterogeneously distributed sub-
population is functionally distinct from the otherwise homogeneous group of fast
spiking interneurons. Suffice to say we must keep chipping away at these un-
knowns, if only to test how significantly they affect the functional organization
of these microcircuits.
Much of my work here has only been possible through recent advances in
genetic modifications, opto- and chemogenetics and technological breakthroughs
such as the silicon microprobes that have uniquely enabled us to record multiple
neurons of interest in an awake behaving animal. Building on the vast body of
work by researchers before us, these new tools and techniques open up new
questions and more answers; and hopefully, ultimately new types of questions.
It is a great time to be a neuroscientist, and I look forward to what the coming
decades may bring. Hopefully some of this work will stand the test of times to
come.
“Look at me: still talking when there’s science to do”
- GlaDOS
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